Skip to main content

Table 5 (abstract P353). Ewing’s Sarcoma Phase I Demographics

From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

 

Vigil®

Matched Comparator (MC)a

Tum or Location Harvest (Lung/Soft Tissue/Other)

13/0/3

11/2/1

Sex (M/F)

12/4

7/7

Age median (range)

19 (59–12)

17 (30–12)

Performance (ECOG 0, 1)

16

14

Ethnicity (Caucasian/Other)

13/3

12/2

Prior Systemic Tx (Frontline/2nd/=3rd)

1/5/10

3/4/7

General Surgery Harvest (Yes/No)

16/0

14/0

  1. a3 insufficient viable tumor cells, 6 contaminants, 5 sought other management
Back to article page